Combined Effects of Nasal Ketamine and Trauma-Focused Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder: A Pilot Case Series.
Judith RohdeElena HickmannMarco BuchmannGolo KronenbergStefan VetterErich SeifritzBirgit KleimSebastian OlbrichPublished in: Behavioral sciences (Basel, Switzerland) (2024)
Despite potential variations in clinical profiles among the patients, the therapy program demonstrated positive outcomes for all participants. Nasally administered ketamine was well tolerated and resulted in immediate symptom reduction in tension, anxiety, and common PTSD symptoms. However, to validate these findings and compare treatment efficacy, future randomized controlled trials are warranted, especially in comparison with trauma-focused therapy alone.
Keyphrases
- end stage renal disease
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- pain management
- social support
- prognostic factors
- peritoneal dialysis
- posttraumatic stress disorder
- trauma patients
- stem cells
- metabolic syndrome
- current status
- human health
- mesenchymal stem cells
- bone marrow
- chronic pain
- climate change
- combination therapy
- meta analyses